Search results for "Limited disease"
showing 2 items of 2 documents
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter …
2020
ABSTRACT Resection of colorectal liver metastases (CRLM) is a potential curative treatment for patients with metastatic colorectal cancer (mCRC) with liver-limited disease (LLD). Although long-term survival improved considerably within the last decades, high recurrence rates of 50-75% after resection remain a major challenge.Tecemotide (L-BLP25) is an antigen-specific cancer vaccine inducing immunity against mucin-1 (MUC1). The LICC trial aimed to improve survival in patients with mCRC after R0/R1 resection of CRLM. LICC was a binational, randomized, double-blind, placebo-controlled, multicenter phase 2 study including patients with R0/R1 resected CRLM without evidence of metastatic disease…
Activation of Grapevine Defense Mechanisms: Theoretical and Applied Approaches
2011
part 4.; International audience; Grapevine, as other plants, possesses an innate immune system that usually prevents infection by pathogens. General elicitors are compounds of different biochemical families capable of inducing plant defense reactions. In grapevine, the cascade of defense events induced by elicitors has been studied among others in cell suspensions. The perception of the elicitor triggers signaling events that allow the activation of defense genes encoding PR proteins and other proteins involved in phytoalexin production and cell wall reinforcement. The grapevine phytoalexins resveratrol and derivated compounds have been largely studied. In addition to their antimicrobial ac…